Clindamycin-13C,D3

CAS: 2140264-63-5

Ref. TR-C579992

Produktinformation

• Name: Clindamycin-13C,D3
• Synonyme: Methyl 7-Chloro-6,7,8-trideoxy-6-[[[(2S,4R)-1-methyl-13C,D3-4-propyl-2-pyrrolidinyl]carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside, trans-α-Methyl 7-Chloro-6,7,8-trideoxy-6-(1-methyl-13C,D3-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-D-galacto-octopyranoside, (2S-trans)-Methyl 7-Chloro-6,7,8-trideoxy-6-[[(1-methyl-13C,D3-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-L-threo-α-D-galacto-octopyranoside, 7(S)-Chloro-7-deoxylincomycin-13C,D3, 7-CDL-13C,D3, 7-Chloro-7-deoxylincomycin-13C,D3, 7-Chlorolincomycin-13C,D3, 7-Deoxy-7(S)-chlorolincomycin-13C,D3, Antirobe-13C,D3, Chlolincocin-13C,D3, Cleocin-13C,D3, Clincin-13C,D3, ClindaDerm-13C,D3, Clindam-13C,D3, Clinimycin-13C,D3, Dalacin C-13C,D3, Dalacin V-13C,D3, Dalacine-13C,D3, Klimicin-13C,D3
• Marke: TRC
• Beschreibung: Stability HygroscopicApplications Clindamycin-13C,D3 is the labeled analog of Clindamycin (C580000, HCl salt), a semi-synthetic antibiotic prepared from Lincomycin. Antibacterial.References Birkenmeyer, R.D., et al.: J. Med. Chem., 13, 616 (1970); Oesterling, et al.: J. Pharm. Sci., 59, 63 (1970); Gray, J.E., et al.: Toxicol. Appl. Pharmacol., 21, 516 (1972); Brown, L.W., et al.: Anal. Profiles Drug Subs., 10, 75 (1981)

Chemische Eigenschaften

• Molekulargewicht: 428.99
• Formel: CC₁₇D₃H₃₀ClN₂O₅S
• Farbe/Form: Off White Solid
• InChl: InChI=1S/C18H33ClN2O5S/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25)/t9-,10+,11-,12+,13-,14+,15+,16+,18+/m0/s1/i3+1D3
• InChI Key: InChIKey=KDLRVYVGXIQJDK-ARPHVQDSSA-N
• SMILES: [2H][13C]([2H])([2H])N1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@H]1O[C@H](SC)[C@H](O)[C@@H](O)[C@H]1O